Binge Eating Disorder Market by Product (Diagnostics, Treatments), End-User (Hospitals, Specialty Clinics) - Global Forecast 2024-2030
The Binge Eating Disorder Market size was estimated at USD 556.42 million in 2023 and expected to reach USD 587.85 million in 2024, at a CAGR 5.98% to reach USD 835.76 million by 2030.
Binge eating disorder (BED) is recognized as an eating disorder described by recurrent episodes of consuming large quantities of food, often quickly, accompanied by a feeling of loss of control during the bingeing and experiencing shame, distress, or guilt afterward. It differs from overeating in its frequency and severity, and it's classified as a significant mental health condition requiring attention. A growing awareness and understanding of BED as a significant health issue have led to more people seeking treatment. Additionally, advancements in treatment options, including cognitive behavioral therapy (CBT), medications, and personalized therapy sessions, have provided effective means for management, acting as a significant driver for the binge eating disorder market. Despite the growth prospects, a lack of awareness and the stigma associated with mental health and eating disorders hinders individuals from seeking treatment. Moreover, the high cost of therapy and lack of insurance coverage in some areas pose significant barriers to accessing effective treatment options. However, the integration of advanced technology in treatment processes, such as telehealth services and mobile applications for self-management, offers new ways to support individuals in remote or underserved locations. Additionally, ongoing research and development are leading to novel therapeutic drugs and interventions, expanding the range of treatment options available.
Regional InsightsIn the Americas, increasing awareness and diagnosis of binge eating disorder has resulted in significant adoption of both pharmacological and non-pharmacological treatments, which has led to a robust market performance in this region. The FDA's approval of medications specific to BED and coverage of therapy sessions by insurance companies contribute to the growth. In the EMEA region, the market performance is influenced by a growing awareness of BED as a distinct medical condition. Europe, with advanced healthcare systems and widespread availability of treatment options, including cognitive behavioral therapy (CBT), has been contributing majorly to the growth of EMEA’s binge eating disorder market. The Middle East and Africa, however, exhibit slower growth owing to limited awareness and healthcare infrastructure. The APAC region is witnessing a gradual increase in the recognition of binge eating disorder and its treatment market, driven by the rise of mental health awareness. However, the region faces challenges such as cultural stigmas around mental health and a paucity of specialized healthcare providers.
Market InsightsMarket Dynamics
The market dynamics represent an ever-changing landscape of the Binge Eating Disorder Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
Market Drivers
- Increasing public health campaigns and education efforts around binge eating disorder
- Rising healthcare expenditure and insurance coverage for mental health services
Market Restraints
- High cost associated with binge eating disorder treatments
Market Opportunities
- Emergence of digital health solutions for binge eating disorder treatments
- Advancements in diagnosis and treatment of eating disorders
Market Challenges
- Stigma and lack of awareness about binge eating disorder treatments
Market Segmentation Analysis
- Product: Need for efficient diagnosis to accurately identify BED and any comorbid conditions
- End-User: Higher preferences for hospitals with comprehensive services, essential for addressing the complex needs of BED patients
Market Disruption Analysis
- Porter’s Five Forces Analysis
- Value Chain & Critical Path Analysis
- Pricing Analysis
- Technology Analysis
- Patent Analysis
- Trade Analysis
- Regulatory Framework Analysis
FPNV Positioning MatrixThe FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Binge Eating Disorder Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share AnalysisThe market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Binge Eating Disorder Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent DevelopmentsMonte Nido & Affiliates Expands Eating Disorder Treatment with New Day Treatment Location in HoustonMonte Nido & Affiliates, a provider of eating disorder treatments in the US, launched Monte Nido Houston's eating disorder day treatment in the Memorial City area, targeting both adolescents and adults of all genders. This new-day treatment program aims to bridge the gap from intensive residential care to outpatient therapy, enhancing the journey towards enduring recovery.
Equip Partnership Adds Eating Disorder Support to Accolade's Trusted Partner EcosystemAccolade, Inc. has announced a strategic partnership with Equip, an innovative virtual treatment program to combat eating disorders from the comfort of one's home. This collaboration enriches Accolade's trusted partner ecosystem, extending vital services to those battling eating disorders by fostering a secure and effective recovery environment that aligns with the highest standard of care in this field.
InsideOut Institute's USD 8 Million Funding Enhances Support for Eating DisordersIn a significant advancement for the treatment and support of individuals with eating disorders in Australia, the Australian Government has allocated funding towards the award-winning eClinic and the innovative Digital GP Hub, spearheaded by the InsideOut Institute, a joint initiative between Sydney Local Health District and the University of Sydney. This funding includes a USD 4 million grant for the eClinic, an online platform providing evidence-based eTherapy programs, and an additional USD 4 million to support the creation of the Digital GP Hub, equipped with digital tools like eScreener and Clinical Decision Support Tool, aimed at enhancing GPs' ability to identify, diagnose, and treat eating disorders efficiently.
Strategy Analysis & RecommendationThe strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Binge Eating Disorder Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company ProfilesThe report delves into recent significant developments in the Binge Eating Disorder Market, highlighting leading vendors and their innovative profiles. These include Alsana, Inc., Alvogen, Amneal Pharmaceuticals, Inc., Apotex Inc., Ascent Pharmaceuticals, Inc., BALANCE Eating Disorder Treatment Center, Carolina House Eating Disorder Treatment Center, Center for Change, Eating Disorders Treatment Center, Eating Recovery Center, Equip Health Medical, P.C., Hikma Pharmaceuticals PLC, Mallinckrodt PLC, Monte Nido & Affiliates Holdings, LLC, Montecatini Eating Disorder Treatment Center, Natural Food Therapy, Red Oak Recovery, Rhodes Pharmaceuticals L.P. by Purdue Pharma L.P., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, TalktoAngel, The London Centre for Eating Disorders and Body Image Ltd., Timberline Knolls Residential Treatment Center, Veritas Collaborative, and Viatris Inc..
Market Segmentation & CoverageThis research report categorizes the Binge Eating Disorder Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Product
- Diagnostics
- Treatments
- Medications
- Anticonvulsant
- Antidepressants
- Psychotherapy
- Cognitive Behavioral Therapy
- Dialectical Behavior Therapy
- Interpersonal Psychotherapy
End-UserHospitalsSpecialty ClinicsRegion
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year